Hypertensive Medications in Competitive Athletes

Abstract

Hypertension is the most common cardiovascular disease in athletes. It is an important cause of long-term morbidity and mortality, even in a fit, athletic population. Management options to reduce these long-term risks exist that have minimal impact on athletic performance. Identification and management of underlying lifestyle factors and diseases that may lead to secondary hypertension is critical. These include substance abuse, medications, and underlying medical conditions. After evaluation and management of these issues, medications can be used to reduce blood pressure. In the athletic population, first-line medication treatment should include ACE inhibitors, angiotensin II receptor blockers (ARB), and calcium channel blockers (CCB). The response to treatment should be followed closely to ensure adequate blood pressure control. Athletic participation in sports with high dynamic load should be limited in individuals with stage 2 hypertension or stage 1 hypertension with evidence of end organ damage.

Copyright © 2017 by the American College of Sports Medicine. 

 


Autor / Fonte:Henry Pelto Current Sports Medicine Reports 2017, 16 (1): 45-49
Link: http://journals.lww.com/acsm-csmr/pages/articleviewer.aspx?year=2017&issue=01000&article=00014&type=abstract